Tamoxifen modulates cell migration and expression of angiogenesis-related genes in human endometrial endothelial cells

American Journal of Pathology

Volumn 180, Issue 6, 2012, Pages 2527-2535

  Helmestam, Malin ^a   Andersson, Helén ^a   Stavreus Evers, Anneli ^a   Brittebo, Eva ^a   Olovsson, Matts ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; MESSENGER RNA; PLACENTAL GROWTH FACTOR; TAMOXIFEN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; CELL GROWTH; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIUM CELL; ENDOTHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; MONOCULTURE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; STROMA CELL;

ANTINEOPLASTIC AGENTS, HORMONAL; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; CYTOCHROME P-450 ENZYME SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOMETRIUM; ENDOTHELIAL CELLS; ESTRADIOL; FEMALE; GENE EXPRESSION REGULATION; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; RECEPTORS, ENDOTHELIN; RNA, MESSENGER; STROMAL CELLS; TAMOXIFEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84861629722     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.02.026     Document Type: Article

References (44)

1. K.D. Barbara, G.F. Leslie From adjuvant therapy to breast cancer prevention: BCPT and STAR Breast J 7 2001 144 157
2. V.C. Jordan Tamoxifen: a most unlikely pioneering medicine Nat Rev Drug Discov 2 2003 205 213
3. E. Chalas, J.P. Costantino, D.L. Wickerham, N. Wolmark, G.C. Lewis, C. Bergman, C.D. Runowicz Benign gynecologic conditions among participants in the Breast Cancer Prevention Trial Am J Obstet Gynecol 192 2005 1230 1237
4. D. Liao, R. Johnson Hypoxia: A key regulator of angiogenesis in cancer Cancer Metastasis Rev 26 2007 281 290
5. H. Okada, A. Tsutsumi, M. Imai, T. Nakajima, K. Yasuda, H. Kanzaki Estrogen and selective estrogen receptor modulators regulate vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in human endometrial stromal cells Fertil Steril 93 2010 2680 2686
6. M. Bläuer, P.K. Heinonen, P. Rovio, T. Ylikomi Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model Eur J Pharmacol 592 2008 13 18
7. G. Krikun, F. Schatz, R. Taylor, H.O.D. Critchley, P.A.W. Rogers, J. Huang, C.J. Lockwood Endometrial endothelial cell steroid receptor expression and steroid effects on gene expression J Clin Endocrinol Metab 90 2005 1812 1818
8. H.O.D. Critchley, R.M. Brenner, T.A. Henderson, K. Williams, N.R. Nayak, O.D. Slayden, M.R. Millar, P.T.K. Saunders Estrogen receptor β, but not estrogen receptor α, is present in the vascular endothelium of the human and nonhuman primate endometrium J Clin Endocrinol Metab 86 2001 1370 1378
9. D.W. Losordo, J.M. Isner Estrogen and angiogenesis: a review Arterioscler Thromb Vasc Biol 21 2001 6 12
10. A.W. Brandenberger, D.I. Lebovic, M.K. Tee, I.P. Ryan, J.F. Tseng, R.B. Jaffe, R.N. Taylor Oestrogen receptor (ER)-α and ER-β isoforms in normal endometrial and endometriosis-derived stromal cells Mol Hum Reprod 5 1999 651 655
11. G. Lecce, G. Meduri, M. Ancelin, C. Bergeron, M. Perrot-Applanat Presence of estrogen receptor β in the human endometrium through the cycle: expression in glandular stromal, and vascular cells Mol Hum Reprod 86 2001 1379 1386
12. E.D. Albrecht, J.S. Babischkin, Y. Lidor, L.D. Anderson, L.C. Udoff, G.J. Pepe Effect of estrogen on angiogenesis in cocultures of human endometrial cells and microvascular endothelial cells Hum Reprod 18 2003 2039 2047
13. FC J.-F. Arnal, A. Billon-Galés, J. Favre, H. Laurell, F. Lenfant, P. Gourdy Estrogen receptors and endothelium Arterioscler Thromb Vasc Biol 30 2010 1506 1512
14. F.E. Murdoch, J. Gorski The role of ligand in estrogen receptor regulation of gene expression Mol Cell Endocrinol 78 1991 C103 C108
15. L.J. Ball, N. Levy, X. Zhao, C. Griffin, M. Tagliaferri, I. Cohen, W.A. Ricke, T.P. Speed, G.L. Firestone, D.C. Leitman Cell type- and estrogen receptor subtype specific regulation of selective estrogen receptor modulator regulatory elements Mol Cell Endocrinol 299 2009 204 211
16. S. Nilsson, S. Makela, E. Treuter, M. Tujague, J. Thomsen, G. Andersson, E. Enmark, K. Pettersson, M. Warner, J.-A. Gustafsson Mechanisms of estrogen action Physiol Rev 81 2001 1535 1565
17. J. Matthews, J.-Å. Gustafsson Estrogen signaling: a subtle balance between ERα and ERβ Mol Interv 3 2003 281 292
18. C. Punyadeera, R. Kamps, S. Defrère, F. Dijcks, A. de Goeij, A. Ederveen, G. Dunselman, P. Groothuis Effects of selective oestrogen receptor modulators on proliferation in tissue cultures of pre- and postmenopausal human endometrium J Steroid Biochem Mol Biol 112 2008 102 109
19. M.J.E. Mourits, K.A.T. Hoor, A.G.J. van der Zee, P.H.B. Willemse, E.G.E. de Vries, H. Hollema The effects of tamoxifen on proliferation and steroid receptor expression in postmenopausal endometrium J Clin Pathol 55 2002 514 519
20. Z. Desta, B.A. Ward, N.V. Soukhova, D.A. Flockhart Comprehensive evaluation of tamoxifen sequential biotransformation by the human cytochrome P450 system in vitro: prominent roles for CYP3A and CYP2D6 J Pharmacol Exp Ther 310 2004 1062 1075
21. D.J. Boocock, K. Brown, A.H. Gibbs, E. Sanchez, K.W. Turteltaub, I.N.H. White Identification of human CYP forms involved in the activation of tamoxifen and irreversible binding to DNA Carcinogenesis 23 2002 1897 1902
22. H.K. Crewe, L.M. Notley, R.M. Wunsch, M.S. Lennard, E.M.J. Gillam Metabolism of tamoxifen by recombinant human cytochrome P450 enzymes: formation of the 4-hydroxy, 4′-hydroxy and N-desmethyl metabolites and isomerization of trans-4-hydroxytamoxifen Drug Metab Dispos 30 2002 869 874
23. H. Andersson, M. Helmestam, A. Zebrowska, M. Olovsson, E. Brittebo Tamoxifen-induced adduct formation and cell stress in human endometrial glands Drug Metab Dispos 38 2010 200 207
24. Y. Shang, M. Brown Molecular determinants for the tissue specificity of SERMs Science 295 2002 2465 2468
25. S. Hague, S. Manek, M.K. Oehler, I.Z. MacKenzie, R. Bicknell, M.C.P. Rees Tamoxifen induction of angiogenic factor expression in endometrium Br J Cancer 86 2002 761 767
26. D.A. McNamara, J. Harmey, J.H. Wang, E. Kay, T.N. Walsh, D.J. Bouchier-Hayes Tamoxifen inhibits endothelial cell proliferation and attenuates VEGF-mediated angiogenesis and migration in vivo Eur J Surg Oncol 27 2001 714 718
27. E.F. Haran, A.F. Maretzek, I. Goldberg, A. Horowitz, H. Degani Tamoxifen enhances cell death in implanted MCF7 breast cancer by inhibiting endothelium growth Cancer Res 54 1994 5511 5514
28. M. Helmestam, A. Stavreus-Evers, M. Olovsson Cadmium chloride alters mRNA levels of angiogenesis related genes in primary human endometrial endothelial cells grown in vitro Reprod Toxicol 30 2010 370 376
29. C. Moberg, R.D. Catalano, D.S. Charnock-Jones, M. Olovsson VEGF-A and Serum withdrawal induced changes in the transcript profile in human endometrial endothelial cells Reprod Sci 17 2010 590 611
30. C. Bredhult, B.-M. Bäcklin, M. Olovsson Effects of some endocrine disruptors on the proliferation and viability of human endometrial endothelial cells in vitro Reprod Toxicol 23 2007 550 559
31. C. Bredhult, L. Sahlin, M. Olovsson Gene expression analysis of human endometrial endothelial cells exposed to op'-DDT Mol Hum Reprod 14 2008 97 106
32. C. Bredhult, L. Sahlin, M. Olovsson Gene expression analysis of human endometrial endothelial cells exposed to Bisphenol A Reprod Toxicol 28 2009 18 25
33. P.Y.J.H. Muller, A.R. Miserez, Z. Dobbie Processing of gene expression data generated by quantitative real-time RT-PCR Biotechniques 32 2002 1372 1374 1376, 1378-1379
34. S. Garvin, U.W. Nilsson, C. Dabrosin Effects of oestradiol and tamoxifen on VEGF, soluble VEGFR-1, and VEGFR-2 in breast cancer and endothelial cells Br J Cancer 93 2005 1005 1010
35. S. Lee, T.T. Chen, C.L. Barber, M.C. Jordan, J. Murdock, S. Desai, N. Ferrara, A. Nagy, K.P. Roos, M.L. Iruela-Arispe Autocrine VEGF signaling is required for vascular homeostasis Cell 130 2007 691 703
36. Z.K. Otrock, J.A. Makarem, A.I. Shamseddine Vascular endothelial growth factor family of ligands and receptors: review Blood Cells Mol Dis 38 2007 258 268
37. Leon Speroff, F. Marc Clinical Gynecologic Endocrinology and Infertility 2005 Lippincott Williams &Wilkins Philadelphia
38. S. Garvin, C. Dabrosin Tamoxifen inhibits secretion of vascular endothelial growth factor in breast cancer in vivo Cancer Res 63 2003 8742 8748
39. T. Schomber, L. Kopfstein, V. Djonov, I. Albrecht, V. Baeriswyl, K. Strittmatter, G. Christofori Placental growth factor-1 attenuates vascular endothelial growth factor-A dependent tumor angiogenesis during β cell carcinogenesis Cancer Res 67 2007 10840 10848
40. Y. Cao Positive and negative modulation of angiogenesis by VEGFR1 Ligands Sci Signal 2 2009 re1
41. C.D. DuSell, E.R. Nelson, B.M. Wittmann, J.A. Fretz, D. Kazmin, R.S. Thomas, J.W. Pike, D.P. McDonnell Regulation of aryl hydrocarbon receptor function by selective estrogen receptor modulators Mol Endocrinol 24 2010 33 46 24:33-46
42. S.Y. Kim, Y.R.S. Laxmi, N. Suzuki, K. Ogura, T. Watabe, M.W. Duffel, S. Shibutani Formation of tamoxifen-DNA adducts via O-sulfonation, not O-acetylation, of alpha-hydroxytamoxifen in rat and human livers Drug Metab Dispos 33 2005 1673 1678
43. M. Ingelman-Sundberg, S.C. Sim, A. Gomez, C. Rodriguez-Antona Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects Pharmacol Ther 116 2007 496 526
44. J.H. Lin, A.Y.H. Lu Inhibition and induction of cytochrome P450 and the clinical implications Clin Pharmacokinet 35 1998 361 390